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Abstract
Background: Possible severe bacterial infections (pSBI) continue to be a leading cause of global neonatal mortality
annually. With the recent publications of simplified antibiotic regimens for treatment of pSBI where referral is not
possible, it is important to know how and where to target these regimens, but data on the incidence and
outcomes of pSBI are limited.
Methods: We used data prospectively collected at 7 rural community-based sites in 6 low and middle income countries
participating in the NICHD Global Network’s Maternal and Newborn Health Registry, between January 1, 2010
and December 31, 2013. Participants included pregnant women and their live born neonates followed for
6 weeks after delivery and assessed for maternal and infant outcomes.
Results: In a cohort of 248,539 infants born alive between 2010 and 2013, 32,088 (13 %) neonates met symptomatic
criteria for pSBI. The incidence of pSBI during the first 6 weeks of life varied 10 fold from 3 % (Zambia) to 36 %
(Pakistan), and overall case fatality rates varied 8 fold from 5 % (Kenya) to 42 % (Zambia). Significant variations in
incidence of pSBI during the study period, with proportions decreasing in 3 sites (Argentina, Kenya and Nagpur,
India), remaining stable in 3 sites (Zambia, Guatemala, Belgaum, India) and increasing in 1 site (Pakistan), cannot
be explained solely by changing rates of facility deliveries. Case fatality rates did not vary over time.
Conclusions: In a prospective population based registry with trained data collectors, there were wide variations
in the incidence and case fatality of pSBI in rural communities and in trends over time. Regardless of these
variations, the burden of pSBI is still high and strategies to implement timely diagnosis and treatment are still
urgently needed to reduce neonatal mortality.
Trial registration: The study was registered at ClinicalTrials.gov (NCT01073475).
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Background
The annual global burden of mortality in children under
age 5 years decreased by 36 % from 9.9 million in 2000
to 6.3 million in 2013, mostly due to reductions in mor-
tality due to pneumonia, diarrhea and measles in chil-
dren aged 2–59 months [1]. Over the same time period,
there was only a 30 % reduction in the annual neonatal
mortality rate from 4 million to 2.8 million, so that the
proportion of under age 5 deaths that occurred in
neonates increased from 38 to 44 % [2]. Most of the
neonatal deaths continue to be attributed to preterm
birth, intrapartum related complications (birth asphyxia)
and neonatal sepsis/meningitis/pneumonia due to pos-
sible severe bacterial infections (pSBI) [1]. The recently
published studies of simplified antibiotic regimens for
treatment of neonatal pSBI provide a potential way to
reduce part of the burden of neonatal mortality in set-
tings where hospitalization is not accepted or available
[3,4], but the impact of these new regimens and optimal
ways to make them available globally is not clear, [5,6]
because there is limited information on the incidence
and case fatality rates of pSBI. To our knowledge, only
one systematic review and meta-analysis estimates the
global incidence and mortality due to neonatal infection,
in one year - 2012 [7]. There is an important need to
confirm these estimates of neonatal pSBI incidence and
case fatality rates using prospectively collected, popula-
tion based data, in which the outcomes of all pregnan-
cies are recorded and to evaluate recent trends over
time, particularly as facility births and survival of pre-
term infants increase.
The diagnosis of possible severe bacterial infection/
neonatal sepsis is challenging even in well-equipped ter-
tiary care facilities in resource rich settings [8,9]. In re-
source limited settings where there is a lack of access to
microbiologic, hematologic and biochemical laboratory
studies, the World Health Organisation’s (WHO) Inte-
grated Management of Childhood Illness (IMCI) algo-
rithm is used to make a clinical diagnosis of possible
severe bacterial infection (pSBI), which includes sepsis,
meningitis and pneumonia in young infants and neo-
nates [10]. However, the signs can be difficult to detect
and non-specific. The algorithm, initially developed in
the first WHO Young Infants Study in the 1990s, found
14 clinical signs and symptoms that predicted isolation
of bacteria in blood or cerebrospinal fluid, or culture
positive severe bacterial disease [11]. These signs and
symptoms were simplified in the second WHO Young
Infants Clinical Signs Study (YICSS) published in 2008
[10]. The YICSS evaluated clinical signs in neonates pre-
senting to primary health care facilities, as detected by
primary care health workers, in 6 countries (Bangladesh,
Bolivia, Ghana, India, Pakistan, and South Africa). Pres-
ence of any one of seven clinical signs and symptoms
predicted severe illness (based on an expert pediatrician’s
assessment) and was associated with a sensitivity and
specificity of 85 and 75 % respectively in 0–6 day old ne-
onates and 74 and 79 % respectively in infants aged 7–
59 days [10]. Since the YICSS signs and symptoms were
not evaluated against blood or cerebrospinal fluid cul-
ture results, the diagnosis likely includes respiratory dis-
tress associated with preterm birth, birth asphyxia, and
viral respiratory infections, but based on available data,
neonates with these signs and symptoms should be
treated for pSBI.
The Eunice Kennedy Shriver National Institute of
Child Health and Human Development (NICHD) Global
Network (GN) for Women and Children’s Health
Research supports a population based Maternal and
Newborn Health (MNH) Registry of pregnant women
and their babies living in rural communities in six low
and lower middle income countries. The Registry has fo-
cused on documentation of pregnancy histories, details
of labor and delivery, accurate and timely measurement
of birth weight and early and late neonatal morbidity
and mortality through day 42 of life, including signs and
symptoms similar to those used in the YICSS, and cause
of death [12]. We used data from live born neonates col-
lected by the MNH Registry between 2010 and 2013 to
estimate the incidence of pSBI using the clinical signs
and symptoms from YICSS, the case fatality rate, and
trends in pSBI incidence and mortality over time.
Methods
Ethics statement
The appropriate Institutional Review Boards and Ethics
Research Committees of all participating institutions and
the Ministries of Health of the respective countries
reviewed and approved participation in the MNH Regis-
try. Prior to initiation of the Registry, approval was also
sought from the participating communities through
sensitization meetings. Study participants were enrolled
in the Registry after they provided written informed con-
sent. No monetary reimbursements were provided to
either individual participants or to communities. A Data
Monitoring Committee, appointed by the NICHD, over-
saw and reviewed the Registry at annual meetings. The
MNH Registry study was registered at ClinicalTrials.gov
(NCT01073475).
Study design, setting and participants
The MNH Registry is an ongoing prospective multicen-
ter cohort study of pregnant women and their babies
who were residents or resided for at least 4 weeks in
rural communities (clusters) in Argentina, Guatemala, 2
states in India, Kenya, Pakistan and Zambia [12]. Details
of the study sites are provided in Table 1 [13]. Pregnant
women are recruited as early as possible during
Hibberd et al. Reproductive Health  (2016) 13:65 Page 2 of 13
pregnancy and followed through day 42 postpartum to
obtain details about the pregnancy, labor and delivery
and the health of the mother and infant. Data are col-
lected by trained staff at enrolment and again at within
7 days of delivery and at 42 days after delivery and
reviewed by medical officers. On enrolment, date of last
menstrual period, estimated delivery date, age, educa-
tion, parity, and status of last child are collected. Infor-
mation collected within 7 days of delivery includes
prenatal care, complications occurring during pregnancy,
Table 1 Details of the study sites in the MNH registry
Location Type Community Setting Human Development
Index a
South Asia
India (Belgaum) – South West Karnataka Semi-urban The study area includes 24 primary health centers
(clusters). Each is managed by a physician medical
officer who works with nursing staff and auxiliary
nurse midwives in associated sub-centers, the most
peripheral outpost of the health care services. There
are 3 tertiary care hospitals and eight secondary care
hospitals serving the region as referral hospitals staffed
by obstetricians, pediatricians and nurses. In addition
to these public sector health facilities, there are several
private sector maternity facilities within the site
catchment area.
0.508
India (Nagpur) – Eastern Maharashtra Semi-urban and rural The study area includes 20 primary health centers, each
served by physician medical officers and nurses. These
areas include 119 sub-centers where basic maternal
and child care are provided. Referral care is provided in
ten tertiary hospitals (2 public sector and 8 private sector),
and 129 secondary hospitals (27 public sector hospitals
and 102 private nursing homes).
0.549
Pakistan – two of five sub districts in
Thatta, Sindh province
Semi-urban and rural The study area includes over 75 health facilities, both
public sector and private fee-for-service, providing maternal
and child health services. This includes 47 primary health
clinics in 24 clusters, 25 secondary care facilities and 3
referral hospitals. Care in health clinics is typically provided
by either paramedical staff, including nurses and lady
health visitors, or non-specialist physicians. Obstetricians
provide care in referral hospitals.
0.595
Sub-Saharan Africa
Kenya – western Kenya in Busia,
Bungoma and Kakamega counties
Rural The study area is served by 23 health facilities in 16 clusters,
most operated by the government and staffed by
nurse-midwives and clinical officers and a single medical
officer. Three hospitals function as referral hospitals. Most
physicians are generalists, with a small number of trained
obstetricians and pediatricians.
0.570
Zambia – Kafue and Chongwe districts,
East Zambia
Rural There are ten clusters, eight of which have health posts.
Care is provided primarily by nurse midwives in the health
posts and by traditional birth attendants for home births.
There are 3 district hospitals and a referral hospital in




Argentina – Corrientes and Santiago del
Estero Provinces, North Argentina
Semi-urban and rural There are six clusters, three in each province. Each cluster
corresponds to a department (municipality) in which the
vast majority of the births occur at a publicly-funded
secondary level hospital. Care is provided primarily by
physicians and midwives. There are 2 Provincial referral
hospitals located in provincial capital cities.
0.828
Guatemala – Chimaltenago region,
Western Highlands
Rural There are 18 clusters served by one referral hospital, 30
health centers, and 42 health posts. Maternal and infant
care in the hospital is provided mainly by obstetricians
and general physicians, in health centers by physicians
and nurses, and in health posts by auxiliary nurses
0.679
a The human development index is a composite statistic of life expectancy, education, and income per capita indicators that are used to rank countries into four
tiers of human development
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mode and location of delivery, status of the mother and
newborn following delivery, sex and birth weight of the
newborn, and neonatal conditions. Maternal and new-
born status and neonatal adverse conditions between de-
livery and 42 days after birth are collected at the second
postpartum visit. Additional study details have been de-
scribed previously [12].
For this secondary data analysis, we included in-
fants born alive between January 1, 2010 and
December 31, 2013 to the pregnant women enrolled
in the seven sites participating in the MNH Registry.
We excluded infants with missing birth weights, as
well as those with birth weight measured more than
7 days after delivery or with unknown timing of
measurement. We excluded babies with missing birth
weights as these were rare in the MNH registry
(<1 %) due to a focus on collection of birth weight
data. The data collection forms changed at the end
of 2013 with symptoms used to define pSBI no lon-
ger collected. Infants for whom the 42 day assess-
ment was conducted using the revised forms were
excluded from analysis. During the study period,
women were enrolled in a total of 118 communities
(clusters) in the seven sites: Argentina, 6 clusters;
Guatemala, 18; Kenya, 16; Zambia, 10; Belgaum,
India, 24; Nagpur, India, 20; Pakistan, 24. In
Argentina, Kenya, Zambia, and Nagpur all clusters
participated throughout the 4 year study period.
However, in Guatemala, Belgaum, India and Pakistan,
only 9 of 18 clusters, 16 of 24 and 20 of 24 clusters
respectively participated throughout the 4 year study
period.
Study outcomes
Possible severe bacterial infection (pSBI)
Estimates of pSBI during the first 6 weeks of life were
derived retrospectively for all live born infants using
symptoms reported on the data collection forms based
on the WHO YICSS criteria [10] to the extent possible
given the information recorded in the registry. The pres-
ence or absence of each of the following symptoms after
delivery was recorded in the registry, with a “yes” re-
sponse considered consistent with pSBI: breathing prob-
lems/difficulty breathing, feeding problems/stopped
suckling/feeding, high fever (>38 ° C or estimated by
touch), hypothermia (<35 ° C or estimated by touch),
convulsions, and bleeding/pus-like discharge from um-
bilicus (Table 2). The MNH Registry variables were not
designed for the diagnosis of pSBI specifically, but to
standardize the data collection on key outcome variables
in pregnant women, mothers and neonates across the
Global Network sites. There was an initial standardized
training conducted with the Site Principal Investigators
(PIs) in the US and then site specific trainings and re-
trainings conducted by the Site PIs to ensure consistency
of the information collected across sites and over time.
In addition, RTI (Data Coordinating Center) monitored
MNH variables over time for deviations and unusual
patterns and when these occurred, they were brought to
the attention of the site PI. In each location the site PI
was assisted by a medically trained registry administrator
who worked with the local data collectors (mostly med-
ical officers) to ensure that data were collected consist-
ently within sites and over time. The registry
administrator and site PI conducted re-trainings at least
once a year and more frequently if deviations or unusual
patterns in data collection were observed.
The specific signs and symptoms of pSBI are challen-
ging, even in resource intense studies [3,4,10] because
they are based in part on parent report (e.g., history of
difficulty breathing and convulsions). The MNH registry
did not collect data on movement when stimulated. The
YICSS measured respiratory rates and trained study staff
on detection of severe chest indrawing, while the MNH
registry reported that any type of breathing problem was
either present or absent. Temperature was measured in
the YICSS but in some Global Network sites was not ac-
tually measured and was only estimated by either the
mother or medical officer. To improve the accuracy of
the diagnosis of pSBI in the MNH registry, infants who
died with cause of death coded “infection” were also
counted as having pSBI. Additionally, text fields used to
record information about symptoms and diagnoses as
well as cause of death were reviewed. Infants with any of
the symptoms listed above, or the words “infection”,
“sepsis”, “possible sepsis”, “septic” (e.g., a septic condi-
tion such as septic rash, septic umbilicus), “meningitis”,
Table 2 Signs and symptoms of possible severe bacterial
infection in the MNH registry
WHO YICSS Signs and
Symptoms
GN MNH Registry Signs and Symptoms
History of difficulty
feeding
Feeding problems; Stopped suckling/feeding




Respiratory rate of 60
breaths per minute or
more
Breathing problems; Difficulty breathing
Severe chest indrawing Breathing problems; Difficulty breathing
Temperature≥ 37.5 ° C High fever (>38 ° C)
Temperature < 35.5 ° C Hypothermia (< 35 ° C)
Other
• Bleeding/pus-like discharge from umbilicus
• Infection recorded as cause of death
• Text indicating infection, sepsis, possible
sepsis, septic conditions, meningitis,
pneumonia
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and/or “pneumonia” in any of the text fields were
counted as having pSBI. All information in the MNH
registry was collected by the medical officers who may
or may not have seen the child when they had the spe-
cific symptom consistent with pSBI, but the medical offi-
cer was responsible for determining whether the MNH
definition of the sign or symptom was met based on
questioning of the mother or data collector, as required
by the MNH training. At most study locations there
were no charts that could be reviewed for additional in-
formation. The number of pSBI episodes and the exact
timing of infection could not be determined, as dates of
diagnosis were not recorded. Microbiologic confirmation
of pSBI was not possible in these rural communities and
facilities.
Case fatality
Neonatal/early infant case fatality after diagnosis of pSBI
was defined as the number of deaths due to any reported
cause among infants with pSBI occurring up to 6 weeks
after birth divided by the number of infants with pSBI.
The cause of death was determined by the registry ad-
ministrator who conducted a basic death audit, per the
MNH manual of operations, by interviewing the birth
attendant, and/or family members and the mother,
whenever possible.
Covariates
Covariates examined included maternal age, maternal
education, location of delivery, mode of delivery, infant
birth weight, infant sex, and early initiation of breast
feeding within an hour of delivery. A hospital was de-
fined as a residential establishment equipped with in-
patient facilities for 24-h medical and nursing care and
staffed with at least one physician providing essential ob-
stetrical/neonatal care (for example, the ability to pro-
vide a caesarean section). A clinic/health center was
defined as a facility that provided (ambulatory) medical
services to a specific group in a population and that did
not have caesarean section capability. Births that oc-
curred at home, whether at the mother’s home, a birth
attendant’s home, or a relative’s home, were grouped to-
gether for analysis. Other delivery locations were infre-
quent. Birth weight was recorded using locally available
scales, calibrated per local facility protocols.
Statistical analysis
Maternal, delivery, and neonatal characteristics were
compared descriptively across the study sites and over
the years studied at each site. The cumulative incidence
of pSBI in the first 6 weeks of life was defined as the
proportion of infants who developed pSBI during the
42 day follow-up period divided by the number of in-
fants studied, with 95 % confidence intervals estimated
using the normal approximation to the binomial distri-
bution. Crude estimates of pSBI incidence and case fatal-
ity rates are reported in text and figures. Percentages of
infants with each symptom of pSBI were also compared
descriptively between the sites.
Statistical testing was conducted using logistic regres-
sion models to compare incidence of pSBI across study
sites, and to examine trends in the proportion with pSBI
by birth year and trends in the proportion with pSBI
who died at each study site, while adjusting for covari-
ates. Adjusted analyses were utilized to compare inci-
dence and assess trends after accounting for differences
across site and over time in the distribution of maternal,
delivery, and neonatal characteristics potentially impact-
ing risk of pSBI. All models included effects for study
site, maternal age (<20, ≥ 20), maternal education (no
formal, primary, secondary/university), cesarean section
delivery (yes, no), facility birth (hospital/clinic/health
center, home/other), infant sex (male, female), infant
birth weight (<2500, ≥2500 g), and initiation of breast-
feeding within 1 h of delivery (yes, no). A test of the null
hypothesis that the incidence of pSBI was the same at all
sites against the alternative that the incidence of pSBI
differed across the sites was conducted using a main ef-
fects model with statistical significance determined by
the Score chi-square test for study site. Site-specific tests
of the null hypothesis that pSBI incidence remained
stable during the study period against the alternative
that incidence changed, and similar tests of trend in case
fatality rates, were conducted using data from all sites in
models that included the main effects above plus birth
year and all 2 way interactions between study site and
each covariate. Birth year was treated as a continuous
variable in order to assess linear trend. Contrasts involv-
ing the site by birth year interaction were used to assess
whether or not changes over time were significant at
each site with statistical significance determined by Wald
chi-square tests. Analyses examining trends in pSBI inci-
dence by birth year and trends in the case fatality rate
were repeated excluding clusters in Guatemala, Belgaum,
and Pakistan that did not participate all four years. In a
secondary analysis, interactions between site, birth year
and facility birth were added to the primary pSBI trends
model in order to test whether trends were the same or
differed by location of delivery at each site. Generalized
estimating equations were used in all models to produce
robust standard errors that accounted for clustering of
women and infants in geographic areas (“clusters”) at
each study site with an independent working correlation
structure specified. Just under 2 % of the data were ex-
cluded from models due to missing values of covariates.
Variables were assumed to be missing at random. Ana-
lyses were implemented using SAS version 9.3 (SAS In-
stitute, Inc., Cary NC).
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Results
Study population
The GN MNH Registry included 266,340 live births be-
tween 2010 and 2013. After exclusions, a total of
248,539 live born infants with birth weight measured
within 7 days after delivery were included in the analysis
(Fig. 1). By 6 weeks after delivery, 241,623 infants were
still alive (97.2 %), 5679 (2.3 %) had died, and 6 week
status was unavailable for 1,237 (0.5 %). The percent of
infants who died ranged from 1.2 % in Argentina to
3.0 % in Pakistan (Table 3). Median age at death for
those who died was 2 to 5 days old depending on study
site.
Maternal, delivery and neonatal characteristics at each
study site
The average age of mothers enrolled ranged from
22 years in Belgaum to 27 years in Pakistan (Table 4). In
Argentina, Kenya, and Nagpur only 3 % of mothers had
no formal schooling. Ten percent of mothers in Zambia
had no formal schooling, 19 % in Guatemala, and 21 %
in Belgaum, while in Pakistan 83 % of mothers had no
formal schooling (Table 4). A secondary or university
level education was achieved by 79 % in Nagpur, 46 % in
Belgaum, 35 % in Zambia, 34 % in Argentina, 26 % in
Kenya, 19 % in Guatemala, and only 9 % in Pakistan.
The majority of mothers had at least one antenatal care
visit with the lowest percent in Pakistan (85 %) and
nearly 100 % in Zambia, Belgaum, and Nagpur.
Caesarean section delivery was infrequent at the Afri-
can sites (1–2 %) and most frequent in Argentina (36 %).
Nearly all women in the Argentina site (99 %) delivered
in hospital. Over 90 % of births in the Indian sites oc-
curred in a facility, compared to 63 % in Zambia, 53 %
in Pakistan and less than half of the births in Guatemala
and Kenya. A clean razor was used to cut the baby’s cord
Fig. 1 Study flow chart: neonates and young infants included in the maternal and newborn health registry and assessed for possible severe
bacterial infection
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and new gloves were used by the birth attendant in al-
most all deliveries, except in Guatemala, where use of a
clean razor was reported for 68 % of deliveries (99 % by
2013) and in Pakistan where use of new gloves was re-
ported for 78 % of births.
Only 1–2 % of infants at each site were from a mul-
tiple birth, and slightly over half were male. Mean birth
weight ranged from 2,677 g in Nagpur to 3,303 g in
Argentina. In Guatemala 75 % of infants were breastfed
within 1 h of delivery, 83 % in Kenya, 85–86 % in the In-
dian sites, and 90 % or more in Argentina and Zambia,
while in Pakistan only 24 % were breastfed within an
hour of birth.
Changes in maternal, delivery and neonatal
characteristics by birth year at each site
In general, maternal educational level increased during
the period 2010–2013 at all sites. The proportion of fa-
cility births remained at 99 % in Argentina throughout
the period. At the other sites the proportion of facility
births increased: from 39 % in 2010 to 58 % in 2013 in
Guatemala, 38 to 52 % in Kenya, 55 to 71 % in Zambia,
92 to 96 % in Belgaum, 90 to 99 % in Nagpur, and 49 to
62 % in Pakistan. The percent of cesarean section deliv-
eries increased at all sites except Zambia where only 1 %
of infants were delivered by cesarean section, from 27 to
40 % of infants in Argentina, 16 to 26 % in Guatemala, 1
to 2 % in Kenya, 10 to 19 % in Belgaum, 18 to 23 % in
Nagpur, and 7 to 12 % in Pakistan. The percent of in-
fants who were breastfed within 1 h of delivery remained
about 90 % in Argentina and 83 % in Kenya throughout
the 4 year period, increased from 85 % in 2010 to 93 %
in 2013 in Zambia, and decreased from 80 to 67 % in
Guatemala, from 90 to 77 % in Belgaum, 92 to 84 % in
Nagpur, and from 31 to 15 % in Pakistan.
pSBI incidence by site
During the study period, 32,088 of the 248,539 live
born neonates met our criteria for pSBI during the
first 6 weeks of life (12.9 %, 95 % CI 12.8–13.0 %). The
percent of infants with pSBI varied widely by study
site, p < 0.001, from a low of 3.2 % (95 % CI 3.0–3.4 %)
in Zambia to 6.4 % (95 % CI 6.2–6.5 %) in Belgaum,
6.4 % (95 % CI 6.1–6.6 %) in Nagpur, 10.6 % (95 % CI
9.9–11.3 %) in Argentina, 13.8 % (95 % CI 13.4–
14.2 %) in Guatemala, 16.5 % (95 % CI 16.1–16.9 %) in
Kenya, and a high of 35.7 % (95 % CI 35.2–36.2 %) in
Pakistan (Fig. 2).
Incidence of pSBI in the first 6 weeks changed signifi-
cantly over time at some sites (Fig. 3). The proportion of
infants with pSBI decreased in Argentina, where nearly
all births occurred in hospital, from 19.0 % (95 % CI
16.4–21.6 %) in 2010 to 7.9 % (95 % CI 6.2–9.7 %) in
2013 (adjusted p = 0.03 accounting for clustering and
maternal and neonatal covariates). In Kenya incidence of
pSBI decreased from 19.1 % (95 % CI 18.2–19.9 %) in
2010 to 10.7 % (95 % CI 10.1–11.4 %) in 2013 (adjusted
p < 0.001), with decreases occurring among infants born
at home as well as in a facility [facility births: 21.4 % (20.0–
22.9 %) to 11.9 % (10.9–12.9 %); home births: 17.6 % (16.5–
18.6 %) to 9.5 % (8.5–10.4 %); adjusted p = 0.91 for a differ-
ence in trend]. In Nagpur, India, the proportion with pSBI
decreased for infants born in a facility [7.8 % (95 % CI 7.2–
8.4 %) in 2010 to 5.3 % (95 % CI 4.9–5.8 %) in 2013, ad-
justed p = 0.01] but not for those born at home [6.6 % (5.2–
8.5 %) to 17.4 % (10.4–27.5 %); adjusted p = 0.35]. In
Guatemala there was a small non-significant decrease in
the proportion of infants with pSBI [14.9 % (13.7–16.0 %)
in 2010 to 13.5 % (12.8–14.1 %) in 2013, adjusted p = 0.11].
However, after exclusion of clusters not participating all
4 years the change in Guatemala became statistically signifi-
cant [14.1 % (12.9–15.4 %) in 2010 to 12.0 % (11.2–12.8 %)
in 2013, adjusted p = 0.03] and these changes did not differ
significantly for home or facility births [facility births:
16.6 % (14.4–18.7 %) to 15.0 % (13.8–16.3 %); home
births: 12.7 % (11.3–14.2 %) to 9.1 % (8.1–10.1 %); ad-
justed p = 0.27 for a difference in trend). There was no
significant change in the overall incidence of pSBI in
the first 6 weeks of life during the study period in
Zambia [3.8 % (3.3–4.2 %) in 2010 to 2.8 % (2.3–3.2 %)
in 2013, adjusted p = 0.19) or in Belgaum [6.2 % (5.9–6.5 %)
in 2010 to 7.7 % (7.3–8.1 %) in 2013, adjusted p = 0.34; with
exclusion of clusters not participating all 4 years, adjusted
p = 0.35]. In contrast, in Pakistan the proportion of
Table 3 Six-week vital status for live born infants 2010–2013 by site
Argentina Guatemala Kenya Zambia Belgaum, India Nagpur, India Pakistan
Number of live births 7,888 26,022 33,724 26,272 77,440 38,303 38,890
Six-week vital status, n (%)
Survived 7,744 (98.2) 25,184 (96.8) 33,239 (98.6) 25,571 (97.3) 75,515 (97.5) 37,218 (97.2) 37,152 (95.5)
Died 96 (1.2) 662 (2.5) 427 (1.3) 463 (1.8) 1,922 (2.5) 935 (2.4) 1,174 (3.0)
Missing 48 (0.6) 176 (0.7) 58 (0.2) 238 (0.9) 3 (0.0) 150 (0.4) 564 (1.5)
Age at death for infants who died
Median day (p25, p75) 3 (1, 8) 5 (2, 16) 3 (1, 12) 2 (1, 7) 3 (1, 7) 3 (1, 8) 5 (2, 15)
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Table 4 Maternal, delivery and neonatal characteristics of live born infants 2010–2013 by site
Characteristic, n (%) Argentina Guatemala Kenya Zambia Belgaum, India Nagpur, India Pakistan
Number of live births 7,888 26,022 33,724 26,272 77,440 38,303 38,890
MATERNAL
Maternal age, y
Mean (SD) 24.5 (6.6) 26.1 (6.6) 24.2 (5.6) 24.7 (6.6) 22.7 (3.0) 23.5 (2.9) 27.6 (4.8)
< 20 2,156 (27) 4,299 (17) 7,308 (22) 6,633 (25) 7,377 (10) 750 (2) 1,446 (4)
20–35 5,114 (65) 19,034 (73) 24,970 (74) 17,528 (67) 69,860 (90) 37,419 (98) 35,150 (91)
> 35 587 (7) 2,675 (10) 1,391 (4) 2,060 (8) 129 (< 1) 106 (< 1) 2,149 (6)
Maternal education - highest level
No formal schooling 201 (3) 4,828 (19) 1,013 (3) 2,691 (10) 15,758 (21) 1,169 (3) 32,284 (83)
Primary 4,893 (63) 16,343 (63) 23,937 (71) 14,328 (55) 25,497 (33) 6,604 (17) 2,917 (8)
Secondary 2,617 (33) 4,563 (18) 7,479 (22) 8,608 (33) 28,432 (37) 22,752 (59) 2,234 (6)
University 117 (1) 277 (1) 1,248 (4) 468 (2) 7,154 (9) 7,731 (20) 1,287 (3)
One or more antenatal visit
Yes 7,445 (95) 25,582 (98) 32,838 (97) 26,139 (100) 77,186 (100) 38,259 (100) 32,842 (85)
No 357 (5) 411 (2) 867 (3) 111 (< 1) 56 (< 1) 16 (< 1) 5,908 (15)
DELIVERY
Mode of delivery
Vaginal 5,072 (64) 20,596 (79) 33,195 (98) 25,976 (99) 66,242 (86) 30,625 (80) 35,584 (92)
Cesarean section 2,813 (36) 5,425 (21) 529 (2) 296 (1) 11,198 (14) 7,678 (20) 3,304 (8)
Location of delivery
Hospital 7,805 (99) 11,534 (44) 4,524 (13) 3,368 (13) 52,519 (68) 26,131 (68) 10,679 (27)
Clinic/health center 18 (< 1) 1,307 (5) 10,054 (30) 13,131 (50) 20,352 (26) 10,699 (28) 9,932 (26)
Home 36 (< 1) 13,131 (50) 18,885 (56) 9,501 (36) 4,234 (5) 1,454 (4) 18,075 (46)
Other 24 (< 1) 50 (< 1) 260 (1) 272 (1) 297 (< 1) 17 (< 1) 187 (< 1)
Clean razor used to cut cord
Yes 7,845 (100) 16,171 (68) 33,587 (100) 25,791 (99) 75,907 (100) 38,047 (100) 38,451 (99)
No 24 (< 1) 7,522 (32) 130 (< 1) 281 (1) 274 (< 1) 108 (< 1) 393 (1)
Birth attendant used new gloves
Yes 7,840 (100) 25,457 (99) 33,189 (98) 25,814 (99) 75,140 (97) 37,383 (99) 30,312 (78)
No 33 (< 1) 303 (1) 528 (2) 246 (1) 1,955 (3) 472 (1) 8,530 (22)
NEONATAL
Multiple birth
Yes 104 (1) 347 (1) 769 (2) 430 (2) 1,067 (1) 565 (1) 796 (2)
No 7,767 (99) 25,675 (99) 32,953 (98) 25,842 (98) 76,367 (99) 37,728 (99) 38,065 (98)
Infant sex
Male 4,071 (52) 13,254 (51) 17,092 (51) 13,830 (53) 40,211 (52) 19,966 (52) 20,369 (52)
Female 3,810 (48) 12,764 (49) 16,632 (49) 12,431 (47) 37,227 (48) 18,333 (48) 18,509 (48)
Birth weight, g
< 1500 64 (1) 155 (1) 61 (< 1) 96 (< 1) 612 (1) 355 (1) 257 (1)
1500–2499 399 (5) 3,228 (12) 892 (3) 1,212 (5) 9,806 (13) 5,439 (14) 5,579 (14)
2500–2999 1,384 (18) 10,151 (39) 6,607 (20) 6,854 (26) 38,785 (50) 22,551 (59) 15,019 (39)
3000–3499 3,121 (40) 9,375 (36) 15,605 (46) 12,104 (46) 23,434 (30) 8,525 (22) 13,649 (35)
3500+ 2,920 (37) 3,113 (12) 10,559 (31) 6,006 (23) 4,803 (6) 1,433 (4) 4,386 (11)
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neonates/young infants with pSBI increased from 26.7 %
(95 % CI 25.9–27.5 %) in 2010 to 55.0 % (95 % CI 53.9–
56.1 %) in 2013, adjusted p < 0.001 (using data from all
clusters or only clusters participating all 4 years).
Signs and symptoms used to determine whether the
infant had pSBI
Across the sites, 60–72 % of neonates/young infants
with pSBI met criteria for pSBI based on a single sign
or symptom, while the remaining babies met criteria
based on multiple symptoms (20–31 % of infants with
pSBI had 2 signs; 10 % or less had 3 or more signs, de-
pending on study site). Breathing problems and/or high
fever were the most frequently reported symptoms at
each study site, followed by feeding problems (Fig. 4).
In Pakistan, the percent of all infants reported with
breathing problems was more than double that re-
ported in the other sites (20 % versus 2–8 % of all in-
fants; 11 % with breathing problems as the only sign
versus 1–4 % at the other sites) and the percent with
high fever was higher (20 % versus 1–11 %; 13 % with
fever as the only sign versus 1–6 % at the other sites).
Combinations involving breathing problems, feeding
problems, and/or high fever were most frequent when
pSBI was determined based on multiple symptoms.
Hypothermia, convulsions, and bleeding/discharge
from the umbilicus were each reported for 2 % or less
of infants at all sites. An indication of infection, sepsis,
meningitis, or pneumonia was reported for <1–2 % of
infants depending on study site.
Case fatality and trends in case fatality rates
Of the 32,088 neonates with pSBI during the first
6 weeks, 27,410 (85 %) survived to 6 weeks of age,
4,564 (14 %) died, and 6–week status was missing for
114 (<1 %). In contrast, only 0.5 % of infants without
pSBI died by 6 weeks. Case fatality rates in neonates
with pSBI varied across sites (Fig. 5). The rate was low-
est in Kenya where 5.2 % (95 % CI 4.6–5.8 %) of infants
with pSBI had died by 6 weeks of age and highest in
Zambia where 41.6 % (95 % CI 38.2–45.0 %) had died.
There were no statistically significant changes in the
case fatality rates in infants with pSBI in the first
6 weeks of life during the 4 year study period at any
site. Case fatality rates associated with signs and symp-
toms varied by site but generally showed that neither
hyperthermia nor umbilical discharge as a single sign is
a risk factor for mortality while multiple signs of pSBI
is (Table 5).
Table 4 Maternal, delivery and neonatal characteristics of live born infants 2010–2013 by site (Continued)
Infant breastfed within 1 h of delivery
Yes 7,054 (90) 19,319 (75) 27,867 (83) 24,037 (92) 63,425 (85) 32,786 (86) 9,492 (24)
No 770 (10) 6,608 (25) 5,818 (17) 2,108 (8) 10,987 (15) 5,344 (14) 29,357 (76)
1The number of infants with pSBI at each site was as follows: Argentina (835/7888); Guatemala 
(3592/26022); Kenya (5563/33724); Zambia (845/26272); Belgaum (4921/77440); Nagpur (2445/38303); 
Pakistan, (13887/38890).
Fig. 2 Cumulative incidence of possible severe bacterial infection (pSBI) through 6 weeks of life in live born infants by study site
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Discussion
In a cohort of 248,539 infants born alive between 2010
and 2013 at 7 population based Global Network sites in
Latin America, Africa, and Asia 32,088 (13 %) neonates
met symptomatic criteria for pSBI. The incidence of
pSBI in the first 6 weeks of life, trends in incidence, and
in case fatality rates in the first 6 weeks for infants with
pSBI varied widely across sites with a 10–fold variation
in incidence of pSBI from 3 % (Zambia) to 36 %
(Pakistan) and an 8 fold variation in case fatality from
5 % (Kenya) to 42 % (Zambia). Our incidence estimates
are in range or somewhat higher than the upper range
recently estimated by Seale et al. [7] in a systematic re-
view and meta-analysis of global incidence of pSBI in
2012 (7.6 %, 95 % confidence interval 6.1–9.2 %), except
for our two extreme sites, Zambia (lower rates) and
Pakistan (higher rates). Unlike Seale et al., we included
all live born infants not just those with birth weight ≥
1,500 g, which may have comparatively inflated our rates
because low birth weight babies may be premature and
may be more likely to have breathing problems that are
not caused by pSBI. Our incidence estimates are likely
higher than Seale’s in some cases because we were un-
able to match the most common sign of pSBI per YICSS,
respiratory rate of 60 breaths per minute, and had to use
a less specific data point of breathing problems and diffi-
culty breathing. It is likely that these respiratory vari-
ables increased the proportion of our pSBI cases that
had respiratory distress due to preterm birth or birth as-
phyxia, both of which are difficult to distinguish from
possible severe bacterial infection, particularly in the first
few days of life. Our case fatality rates are within the
range estimated by Seale et al. (9.8, 95 % confidence
interval 7.4–12.2 %) for Argentina and Pakistan, lower
for Kenya and higher for Guatemala, Zambia, and the
two Indian sites. Although a common protocol was used
for prospective data collection, we note that Zambia had
the lowest incidence of pSBI but the highest case fatality
rate, suggesting that signs and symptoms may have been
underreported in this site. In contrast, Pakistan had the
1Plots are based on crude estimates. P values for tests of whether incidence changed are model-based after
accounting for clustering and covariates as described in Methods. 
Fig. 3 Trends in cumulative incidence of possible severe bacterial infection through 6 weeks of life by study site, 2010–2013
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highest incidence of pSBI and one of the lower case fa-
tality rates, suggesting there may have been over-
reporting of respiratory symptoms or that these symp-
toms were due to the higher rates of preterm birth and
birth asphyxia reported in Pakistan [14]. Overall, our es-
timates, on average, align with Seale et al. [7], which
lends support to the credibility of these findings particu-
larly as these data from the studies contributing to
Seale’s paper and the MNH registry (as described in the
methods above) were obtained in very different ways.
However, the wide variations in pSBI incidence and case
fatality rates, even in our prospective registry with
trained data collectors, indicate continued need for ob-
jective criteria to make a diagnosis of pSBI.
Between 2010 and 2013 there were significant in-
creases in facility deliveries and survival of neonates
born preterm in our study sites as well as in the coun-
tries our sites represent. Against this background, we
found decreases in the incidence of pSBI in the first
6 weeks of life during the period in Argentina, Kenya,
1Categories are not mutually exclusive.  “Other” includes bleeding/discharge from the umbilicus, infection recorded as cause of death, and any 
indication of infection, sepsis, meningitis, or pneumonia recorded in text. 
Fig. 4 Signs and symptoms of possible severe bacterial infection reported in all live born infants by study site
The number of infants with pSBI who died by 6 weeks at each site was: Argentina, 88/830 (6 week 
status missing for 5); Guatemala, 557/3580 (status missing for 12); Kenya, 287/5561 (status missing for 
2); Zambia, 350/842 (status missing for 3); Belgaum, 1547/4921; Nagpur, 691/2439 (status missing for 
6); Pakistan, 1044/13801 (status missing for 86).
1
Fig. 5 Case fatality rates in neonates with possible severe bacterial infection (pSBI) during the first 6 weeks of life by study site
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and Nagpur, India after accounting for clustering and
maternal and neonatal factors. Argentina was the one
site where nearly all infants were born in hospital
throughout the study period, and the decrease in Kenya
occurred among infants born at home as well as in a fa-
cility suggesting that changes at these sites cannot be at-
tributed simply to facility birth. In contrast, in Nagpur,
India, the decrease in pSBI rate occurred among facility
births alone with no significant change in pSBI incidence
among infants born at home. While facility births in-
creased from 49 to 62 % of all births in Pakistan, pSBI
incidence increased during the period for infants born in
a facility as well as for those born at home, after ac-
counting for birth weight and other factors. Reporting or
diagnostic changes may have contributed to the increase
in Pakistan.
Our prospective study has several important strengths.
First, we attempted to define pSBI based on the presence
of any one of seven signs found to be predictive of se-
vere illness in young infants [10]. However, we were lim-
ited in our ability to match all of these signs, mainly
respiratory rate of 60 breaths or more per minute, severe
chest indrawing, and movement when stimulated be-
cause they were not included in the MNH Registry. We
recognize the overlap that breathing problems and diffi-
culty breathing have with problems of prematurity, birth
asphyxia, and non-bacterial illnesses. However, the pro-
portions of infants with specific signs and symptoms are
highly consistent with the ranges published in recent
clinical trials that assessed community based treatment
of neonatal sepsis [3,4]. There was extensive training on
identification of signs and symptoms of pSBI in these tri-
als, but there was still wide variation in the proportion
of infants with signs such as chest indrawing across the
study sites. Our data are also limited by lack of microbi-
ologic confirmation in the rural communities and facil-
ities. Further, we did not have the precise details of
timing of the symptoms in the first 42 days of life, so it
is possible that our incidence estimates are higher than
in other studies reporting pSBI between day 0–27 of life
and lower than in studies reporting pSBI in young in-
fants between day 0–59 of life. We also do not have in-
formation on precise treatment practices by site for
access to health care facilities, care seeking, antibiotic
access across and over time and how these variables may
have impacted case fatality rates. Finally, the MNH
registry does not currently collect reliable information
on referral practices because the ability to refer infants
depends on the availability of referral facilities. Similarly,
location of death is not captured currently and would be
difficult to interpret because of variable access to referral
facilities across the Global Network sites. We recognize
that many of our limitations could have resulted in mis-
classification of pSBI that could have varied by site and
over time, but to move forward, improved diagnostics
for pSBI are urgently needed. Despite these limitations,
the incidence of pSBI at each site is likely indicative of a
significant portion of the neonatal illness burden given
that infants identified as having pSBI were at greatly in-
creased risk of death during the first 6 weeks of life
compared to other infants. We believe that our data are
generalizable based on the similarity with the Seale data
and the standardized data collection across the 7 Global
Network sites.
The high burden of pSBI in neonates and young in-
fants, regardless of definitions and changes in location of
birth, is an important reminder that investment in ways
to reduce delays in early recognition /diagnosis and
Table 5 Case fatality rates in infants with pSBI in the first 6 weeks of life by pSBI criteria
Variable Argentina Guatemala Kenya Zambia Belgaum, India Nagpur,
India
Pakistan
Number of infants with pSBI and
non-missing status
830 3,580 5,561 842 4,921 2,439 13,801
Single sign/symptom, n/N (%) died
Breathing problem/difficulty
breathing
26/316 (8.2) 61/561 (10.9) 63/917 (6.9) 59/190 (31.1) 577/2,153 (26.8) 156/584 (26.7) 250/4,395 (5.7)
Feeding problem/stopped
suckling/feeding
2/55 (3.6) 31/162 (19.1) 16/139 (11.5) 40/87 (46.0) 102/346 (29.5) 67/319 (21.0) 31/203 (15.3)
High fever 1/88 (1.1) 18/1,431 (1.3) 5/1,814 (0.3) 21/156 (13.5) 7/707 (1.0) 8/592 (1.4) 40/4,852 (0.8)
Hypothermia 0/6 (0.0) 11/85 (12.9) 4/88 (4.5) 4/11 (36.4) 34/124 (27.4) 7/32 (21.9) 26/141 (18.4)
Convulsions 0/3 (0.0) 1/8 (12.5) 2/34 (5.9) 1/10 (10.0) 27/60 (45.0) 7/14 (50.0) 16/89 (18.0)
Bleeding/pus-like discharge
from umbilicus
0/42 (0.0) 0/135 (0.0) 1/297 (0.3) 1/39 (2.6) 2/46 (4.3) 0/36 (0.0) 0/252 (0.0)
Infection diagnosis or cause
of death
1/14 (7.1) 26/152 (17.1) 13/68 (19.1) 24/25 (96.0) 72/80 (90.0) 23/27 (85.2) 7/9 (77.8)
>1 sign/symptom, n/N (%) died 58/306 (19.0) 409/1,046 (39.1) 183/2,204 (8.3) 200/324 (61.7) 726/1,405 (51.7) 423/835 (50.7) 674/3,860 (17.5)
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treatment of pSBI continues to be needed and is consist-
ent with the research priorities outlined in the Every
Newborn Action Plan [5]. Priorities for the future in-
clude ways to improve early detection of pSBI in the
community, risk stratification, early access to referral of
those at the greatest risk of mortality and ways to pre-
vent pSBI particularly in the era of increased delivery of
babies in health care facilities.
Conclusions
In a prospective population based registry with trained
data collectors, there were wide variations in the reported
incidence and case fatality of pSBI in rural communities
and in trends over time. Regardless of these variations, the
burden of pSBI is still high and strategies to implement
timely diagnosis and treatment are still urgently needed to
reduce neonatal mortality.
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